» Articles » PMID: 38707953

Hyperuricemia Increases the Risk of Postoperative Recurrence in Chinese Patients with Chronic Rhinosinusitis

Overview
Journal J Inflamm Res
Publisher Dove Medical Press
Date 2024 May 6
PMID 38707953
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Elevated serum uric acid is crucial in the pathophysiology of chronic inflammatory diseases. However, its impact on chronic rhinosinusitis (CRS) recurrence risk is unknown. This study investigates the association between elevated serum uric acid and the risk of CRS recurrence.

Methods: A retrospective cohort study was conducted on 1004 CRS patients (including 638 males and 366 females) who received functional endoscopic sinus surgery. All patients were followed up for more than 2 years, and categorized into subgroups based on phenotype, gender, and postoperative recurrence. Cox regression analysis was performed to evaluate the associations between serum uric acid and the risk of CRS recurrence.

Results: After categorization, 104 males had hyperuricemia, and 54 females presented hyperuricemia. The rate of recurrent CRS in the hyperuricemia group was significantly higher compared to the non-hyperuricemia group in both males and females (P<0.05). In both male and female patients, the rate of hyperuricemia and uric acid levels were elevated in the recurrent CRS group in comparison with the non-recurrent CRS group (P<0.05). Unadjusted and adjusted Cox regression analysis demonstrated that serum uric acid was an independent risk factor for CRS recurrence (P<0.05). The receiver operator characteristic curve showed that serum uric acid was a potential biomarker for predicting the recurrence of CRS and its phenotypes in both genders (P<0.05).

Conclusion: There is a close relationship between elevated serum uric acid and the recurrence risk of CRS and its phenotypes, suggesting that serum uric acid may be a novel biomarker for predicting recurrent CRS.

References
1.
Sun F, Zhao W, Shen H, Fan N, Zhang J, Liu Q . Design of Smart Aggregates: Toward Rapid Clinical Diagnosis of Hyperlipidemia in Human Blood. Adv Mater. 2022; 34(49):e2207671. DOI: 10.1002/adma.202207671. View

2.
Hong S, Kim Y, Cha H, Park J, Kim J, Oh H . Endotype-related recurrence pattern of chronic rhinosinusitis in revision functional endoscopic sinus surgery. Auris Nasus Larynx. 2021; 49(2):215-221. DOI: 10.1016/j.anl.2021.07.010. View

3.
Oka A, Ninomiya T, Fujiwara T, Takao S, Sato Y, Gion Y . Serum IgG4 as a biomarker reflecting pathophysiology and post-operative recurrence in chronic rhinosinusitis. Allergol Int. 2020; 69(3):417-423. DOI: 10.1016/j.alit.2019.12.004. View

4.
Xie S, Zhang C, Xie Z, Zhang J, Zhang H, Jiang W . Serum metabolomics identifies uric acid as a possible novel biomarker for predicting recurrence of chronic rhinosinusitis with nasal polyps. Rhinology. 2023; 61(6):541-551. DOI: 10.4193/Rhin23.236. View

5.
Lv Q, Xu D, Zhang X, Yang X, Zhao P, Cui X . Association of Hyperuricemia With Immune Disorders and Intestinal Barrier Dysfunction. Front Physiol. 2020; 11:524236. PMC: 7729003. DOI: 10.3389/fphys.2020.524236. View